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Editorial
Why we need ethical oversight of quality 
improvement projects
The jury is still out on whether ethical oversight is needed for
quality improvement projects. Many quality practitioners
argue that as long as the quality improvement project is not
primarily research, ethical review is unnecessary. In this editorial,
I would like to defend the opposite view, that ethical over-
sight is indeed desirable for most initiatives to improve the
quality of health care.
Let us redefine the nature of health care. Much of health
care would amount to reckless endangerment or even to bodily
harm if it were not covered by the tacit covenant between
patient and doctor (think of surgery or chemotherapy). Under
this covenant, the doctor is allowed to perform potentially
dangerous treatments as long as she or he acts solely in the
interest of the patient. If the doctor served any master other
than the patient’s welfare, his or her actions would be unlawful.
This is why strict oversight by an external body is needed when
doctors perform research, an activity that aims to produce
knowledge for the benefit of society, and not necessarily to
help the patient.
Clearly, the rule should be: for anything the patient requested
you do not need external ethical oversight, for anything else
that affects patient care you do. Unfortunately, the rule that is
prevalent today has perversely shifted to this: for medical
research you need ethical oversight, for anything else you don’t.
Several authors have endeavoured to define ‘research’ to
delimit the jurisdiction of ethics committees [1–3]. Others
have argued that the emphasis on research is misguided: what
matters is whether an activity entails risk to patients [4]. Since
health care is intrinsically risky, all decisions that bear on health
care should be subjected to ethical oversight—except, that is,
when they are specifically authorized by the patient in the
course of clinical care. Many management and policy deci-
sions that may have a significant impact on care are made in
the background, unbeknownst to the patient. Here are a few
examples: ‘gag rules’ that limit the doctor’s ability to discuss
treatment options not covered by a health insurance contract,
reductions in health care personnel to improve productivity,
structural overwork of doctors in training, limitation of
resources to investigate medical mishaps, reliance on paper-
based patient records, pharmacy formulary decisions, closure
(or opening) of hospital beds. Such decisions may threaten or
enhance patients’ welfare yet are not made in response to patients’
demands. That they are not overseen by an ethics committee
suggests that health care management in 2004 is like medical
research before Nuremberg: unsupervised and possibly harmful.
Quality improvement projects face the same predicament.
While such projects aim to improve or maintain the quality of
patient care, those in charge cannot be sure that the intervention
will be effective. A risk exists that the proposed innovation will
be ineffective or even harmful. Furthermore, evaluations of
quality improvement projects are much like research in terms
of the risks they pose for patients. The key difference is that
their goal is to produce locally relevant knowledge, not generally
applicable scientific knowledge. As with medical research, the
proponents of the project have too much at stake to be trusted
with an even-keeled assessment of potential harms and benefits.
Such an assessment should be done by a body whose sole
mandate would be to look after patients’ interests—let us call it
a ‘management ethics committee’. This committee would
assess the merits of all proposed quality improvement projects
(and by extension, any management decision that may impact
on the quality of care), and decide whether the project may or
may not go forth. The analysis would be guided by ethics
frameworks proposed for public health activities, and focus
on the expected effectiveness of the intervention, the associated
risks and burdens, and fairness in the distribution of benefits
and risks [5]. The committee should include representatives of
management, of the health professions and possibly of patients.
Several objections can be raised to this proposal. Some would
say that quality improvement does not require ethical over-
sight because it is a moral obligation of health care systems—
not to do it would be unethical. This is correct, and the same
argument is true for medical research. However, that the general
area of activity is commendable does not imply that any given
project is acceptable. ‘Quality improvement’ is the aim of the
project, not a guaranteed result.
Another objection to ethical oversight of quality improve-
ment projects is that it would be impractical or impossible to
obtain individual informed consent [2]. This is also correct.
However, ethical oversight does not necessarily imply individual
informed consent [6,7]. The requirement for individual consent
is routine in medical research, where the proposed intervention
is to be applied to the individual, and the risks and benefits
are borne by the same. In contrast, most quality improvement
projects are systemic. If doctors’ working hours are reduced in
order to decrease fatigue and the likelihood of errors, an indi-
vidual patient cannot elect to be treated by an intern at the
end of a 36-hour shift. Individual consent is simply not relevant
in such a case [7]. I would suggest that obtaining an independent
assessment of risks and benefits for the project is sufficient in
most cases, and formal consent to participate is unnecessary.
In some circumstances, the patient population directly
affected by the project may need to be formally consulted.
How such a community informed consent can be obtained is
an open question—perhaps from a panel of former patients,
or from other representatives of society at large, much like the
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Citizens Council established by the National Institute for Clinical
Excellence in the UK (www.nice.org.uk). The body that grants
consent should be independent from the ethics committee that
has authorized the launch of the quality improvement initiative.
Community informed consent may be particularly useful when
the proposed systemic intervention poses a substantial risk to
patient health, and not merely, say, to the confidentiality of
medical records. For individual interventions, individual consent
remains an option.
Another possible objection is that ethical oversight would
add an unseemly layer of bureaucracy to hospital operations,
stifling, rather than encouraging, quality improvement initi-
atives. Similar arguments are sometimes heard from medical
researchers who consider the review of their projects by
research ethics committees as an obstacle to research. No doubt
this is in part true. But surely principle should take precedence
over practicality. Furthermore, even though ethical oversight
requirements may reduce the number of quality improvement
projects, those that will get done will be better formalized and
more thoroughly evaluated than is currently the case. Quality
improvement projects are sometimes felt to require less rigour
in conception and less care in implementation than scientific
research projects. There is little justification for such uneven
standards.
Finally, ethical oversight of quality improvement projects
appears to place an unfair burden on innovations, as opposed
to the status quo. This is true, but one has to start somewhere.
Hopefully, hospital processes that pose the most problems
are the most likely to be subjected to a quality improvement
initiative. Hence, ethical oversight will be directed at the most
problematic areas first. Furthermore, with time, most hospital
procedures that affect patient care will change, and hence will be
screened by the management ethics committee. In this way,
the work of management ethics committees will ensure that the
functioning of hospitals is primarily concerned with the needs
of patients.
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